healthletic's bpc-157 arginate salt (Arginate Salt) pharmaceutical-grade bpc-157 arginine salt BPC-157:

Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine , 2022

Broader analysis across multiple clinical trials suggests that approximately 10% of patients across all indications and doses may discontinue semaglutide due to GI complaints, which is comparable to or slightly higher than other GLP-1 receptor agonists

Thats because research-grade peptides arent subject to the same quality controls as their pharmaceutical-grade counterparts, and many have purity levels as low as 60%.4 Thus, they have a greater potential to be toxic and cause the life-threatening adverse effects we discuss under Therapeutic peptide safety. You can find pharmaceutical-grade versions of non-GLP-1 peptides online, but you need to be quite careful if youre seeking a peptide therapy for something like muscle growth, immune function, longevity, or another health concern unrelated to weight loss

Gap BPC 157 therapy was associated with a reduction in the musculoskeletal defect that had already occurred in the early stages, from the first post-operative day (Figure 7, Figure 8, Figure 9, Figure 10, Figure 11 and Figure 12)